HM Payson & Co’s Takeda Pharmaceutical TAK Stock Holding History

HM Payson & Co’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.6K	Hold	100	–	–	﹤0.01%	1070
2026 Q1	$1.85K	Hold	100	–	–	﹤0.01%	1051
2025 Q4	$1.56K	Hold	100	–	–	﹤0.01%	1079
2025 Q3	$1.46K	Hold	100	–	–	﹤0.01%	1026
2025 Q2	$1.55K	Hold	100	–	–	﹤0.01%	945
2025 Q1	$1.49K	Hold	100	–	–	﹤0.01%	980
2024 Q4	$1.32K	Hold	100	–	–	﹤0.01%	988
2024 Q3	$1.42K	Hold	100	–	–	﹤0.01%	1001
2024 Q2	$1.29K	Hold	100	–	–	﹤0.01%	943
2024 Q1	$1.39K	Sell	100 -186	-65%	-$2.71K	﹤0.01%	916
2023 Q4	$4.08K	Sell	286 -503	-64%	-$7.14K	﹤0.01%	877
2023 Q3	$12.2K	Buy	789 +503	+176%	+$7.79K	﹤0.01%	797
2023 Q2	$4.49K	Hold	286	–	–	﹤0.01%	860
2023 Q1	$4.71K	Sell	286 -105	-27%	-$1.67K	﹤0.01%	861
2022 Q4	$6.1K	Buy	391 +105	+37%	+$1.47K	﹤0.01%	787
2022 Q3	$4K	Hold	286	–	–	﹤0.01%	871
2022 Q2	$4K	Hold	286	–	–	﹤0.01%	915
2022 Q1	$4K	Sell	286 -745	-72%	-$10.9K	﹤0.01%	931
2021 Q4	$14K	Hold	1,031	–	–	﹤0.01%	824
2021 Q3	$17K	Hold	1,031	–	–	﹤0.01%	768
2021 Q2	$17K	Sell	1,031 -10	-1%	-$170	﹤0.01%	773
2021 Q1	$19K	Hold	1,041	–	–	﹤0.01%	769
2020 Q4	$19K	Hold	1,041	–	–	﹤0.01%	780
2020 Q3	$19K	Hold	1,041	–	–	﹤0.01%	741
2020 Q2	$19K	Hold	1,041	–	–	﹤0.01%	678
2020 Q1	$16K	Sell	1,041 -251	-19%	-$4.55K	﹤0.01%	683
2019 Q4	$25K	Sell	1,292 -1,981	-61%	-$37.9K	﹤0.01%	692
2019 Q3	$56K	Sell	3,273 -1,236	-27%	-$21.4K	﹤0.01%	573
2019 Q2	$80K	Buy	+4,509	New	+$82K	﹤0.01%	521

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

HM Payson & Co's TAK Position: Q2 2026 in Review

HM Payson & Co held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 100 shares worth $1.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1070.

HM Payson & Co first reported a position in TAK in Q2 2019 and has held it in 29 quarters since. The position peaked at $80K in Q2 2019. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

HM Payson & Co held 100 shares of Takeda Pharmaceutical worth $1.6K as of Q2 2026.
HM Payson & Co left its Takeda Pharmaceutical share count unchanged in Q2 2026.
Takeda Pharmaceutical made up ﹤0.01% of HM Payson & Co's portfolio in Q2 2026, its #1070 holding.
HM Payson & Co first reported a position in Takeda Pharmaceutical in Q2 2019 and has held it in 29 quarters since.
HM Payson & Co's Takeda Pharmaceutical position peaked at $80K in Q2 2019.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.